Evaluation of efficacy of Kremezin in peripheral arterial disease patients with chronic kidney disease.
Phase of Trial: Phase II
Latest Information Update: 22 Jul 2016
At a glance
- Drugs Charcoal (Primary)
- Indications Kidney disorders; Peripheral arterial disorders
- Focus Therapeutic Use
- 20 Jul 2016 Planned End Date changed from 31 Mar 2017 to 31 Mar 2018.
- 28 May 2014 New trial record